Effects of Physical Tracing on Estimates of Loss to Follow-Up, Mortality and Retention in Low and Middle Income Country Antiretroviral Therapy Programs: A Systematic Review
Open Access
- 12 February 2013
- journal article
- review article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (2) , e56047
Abstract
A large proportion of patients receiving antiretroviral therapy (ART) in low and middle income countries (LMICs) have unknown treatment outcomes and are classified as lost to follow-up (LTFU). Physical tracing of patients classified as LTFU is common; however, effects of tracing on outcomes remains unclear. The objective of this systematic review is to compare estimates of LTFU, mortality and retention in LMIC in cohorts of patients with and without physical tracing. We systematically identified studies in LMIC programmatic settings using MEDLINE (2003–2011) and HIV conference abstracts (2009–2011). Studies reporting the proportion LTFU 12-months after ART initiation were included. Tracing activities were determined from manuscripts or by contacting study authors. Studies were classified as “tracing studies” if physical tracing was available for the majority of patients. Summary estimates from the 2 groups of studies (tracing and non-tracing) for LTFU, mortality, stop of ART, transfers out, and retention on ART were determined. 261 papers and 616 abstracts were identified of which 39 studies comprising 54 separate cohorts (n = 187,666) met inclusion criteria. Of those, physical tracing was available for 46% of cohorts. Treatment programs with physical tracing activities had lower estimated LTFU (7.6% vs. 15.1%; p<.001), higher estimated mortality (10.5% vs. 6.6%; p = .006), higher retention on ART (80.0 vs. 75.8%; p = .04) and higher retention at the original site (80.0% vs. 72.9%; p = .02). Knowledge of patient tracing is critical when interpreting program outcomes of LTFU, mortality and retention. The reduction of the proportion LTFU in tracing studies was only partially explained by re-classification of unknown outcomes. These data suggest that tracing may lead to increased re-engagement of patients in care, rather than just improved classification of unknown outcomes.Keywords
This publication has 53 references indexed in Scilit:
- Virological Response and HIV Drug Resistance 12 Months After Antiretroviral Therapy Initiation at 2 Clinics in NigeriaClinical Infectious Diseases, 2012
- Toward Universal Access to HIV Counseling and Testing and Antiretroviral Treatment in Ethiopia: Looking Beyond HIV Testing and ART InitiationAIDS Patient Care and STDs, 2010
- Effectiveness of highly active antiretroviral therapy administered by general practitioners in rural South AfricaEuropean Journal of Clinical Microbiology & Infectious Diseases, 2008
- Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in TanzaniaBMC Infectious Diseases, 2008
- Patient Retention in Antiretroviral Therapy Programs in Sub-Saharan Africa: A Systematic ReviewPLOS Medicine, 2007
- Evaluation of a workplace HIV treatment programme in South AfricaAIDS, 2007
- A Program to Provide Antiretroviral Therapy to Residents of an Urban Slum in Nairobi, KenyaJournal of the International Association of Physicians in AIDS Care, 2007
- HIV Treatment in a Conflict Setting: Outcomes and Experiences from Bukavu, Democratic Republic of the CongoPLOS Medicine, 2007
- Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western KenyaAIDS, 2006
- Predictors of Virologic Failure and Resistance in HIV-Infected Patients Treated with Nevirapine- or Efavirenz-Based Antiretroviral TherapyClinical Infectious Diseases, 2004